BNS-22
|
- $129 - $541
- Product name: BNS-22
- CAS: 1151668-24-4
- MF: C24H25NO5
- MW: 407.46
- EINECS:-0
- MDL Number:MFCD22628799
- Synonyms:BNS-22;8-[(3,4-Dihydro-2H-quinolin-1-yl)carbonyl]-5,7-dimethoxy-4-propyl-2H-chromen-2-one;BNS-22 >=98% (HPLC);2H-1-Benzopyran-2-one, 8-[(3,4-dihydro-1(2H)-quinolinyl)carbonyl]-5,7-dimethoxy-4-propyl-;BNS-22 (BNS22);5,7-dimethoxy-4-propyl-8-(1,2,3,4-tetrahydroquinoline-1-carbonyl)-2H-chromen-2-one
4 prices
Selected condition：
Brand
- AK Scientific
- Sigma-Aldrich
Package
- 5mg
- 25mg
- ManufacturerAK Scientific
- Product numberX5941
- Product descriptionBNS-22
- Packaging5mg
- Price$175
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product numberX5941
- Product descriptionBNS-22
- Packaging25mg
- Price$541
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0436
- Product descriptionBNS-22 ≥98% (HPLC)
- Packaging5mg
- Price$129
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0436
- Product descriptionBNS-22 ≥98% (HPLC)
- Packaging25mg
- Price$404
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | X5941 | BNS-22 | 5mg | $175 | 2021-12-16 | Buy |
| AK Scientific | X5941 | BNS-22 | 25mg | $541 | 2021-12-16 | Buy |
| Sigma-Aldrich | SML0436 | BNS-22 ≥98% (HPLC) | 5mg | $129 | 2024-03-01 | Buy |
| Sigma-Aldrich | SML0436 | BNS-22 ≥98% (HPLC) | 25mg | $404 | 2024-03-01 | Buy |
Properties
Boiling point :622.7±55.0 °C(Predicted)
Density :1.226±0.06 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: soluble2mg/mL (clear solution; warmed)
form :powder
pka :-1.34±0.20(Predicted)
color :white to beige
Density :1.226±0.06 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: soluble2mg/mL (clear solution; warmed)
form :powder
pka :-1.34±0.20(Predicted)
color :white to beige
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|